Evidence map›Paper›PMID 25898175›Full record

ArticleScientific reports2015

Sulfonium salts as leaving groups for aromatic labelling of drug-like small molecules with fluorine-18.

Kerstin Sander, Thibault Gendron, Elena Yiannaki, Klaudia Cybulska, Tammy L Kalber, Mark F Lythgoe, Erik Årstad

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Fully Automated Azeotropic Drying-Free Synthesis of [Molecules (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. One-Step Synthesis of [ACS central science · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Development of [Journal of medicinal chemistry · 2021
    Article
  11. Sequential Ir/Cu-Mediated Method for theJournal of the American Chemical Society · 2021
    Article
  12. Article
  13. Site-Selective Late-Stage Aromatic [Angewandte Chemie (International ed. in English) · 2020
    Article
  14. Synthesis and in vivo evaluation of [European journal of nuclear medicine and molecular imaging · 2019
    Article
  15. Article
  16. FacileNature protocols · 2019
    Article
  17. Article
  18. Chemistry for Positron Emission Tomography: Recent Advances inAngewandte Chemie (International ed. in English) · 2019
    Review
  19. Article
  20. [ACS omega · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kerstin SanderInstitute of Nuclear Medicine - Radiochemistry, University College London, 235 Euston Road (T-5), London NW1 2BU, UK.
Thibault GendronInstitute of Nuclear Medicine - Radiochemistry, University College London, 235 Euston Road (T-5), London NW1 2BU, UK.
Elena YiannakiDepartment of Chemistry, University College London, 20 Gordon Street, London WC1H 0AJ, UK.
Klaudia CybulskaDivision of Biosciences, University College London, Gower Street, London WC1E 6BT, UK.
Tammy L KalberCentre for Advanced Biomedical Imaging, University College London, 72 Huntley Street, London WC1E 6DD, UK.
Mark F LythgoeCentre for Advanced Biomedical Imaging, University College London, 72 Huntley Street, London WC1E 6DD, UK.
Erik Årstad1] Institute of Nuclear Medicine - Radiochemistry, University College London, 235 Euston Road (T-5), London NW1 2BU, UK [2] Department of Chemistry, University College London, 20 Gordon Street, London WC1H 0AJ, UK.

Funding

Cancer Research UK 16463Cancer Research UK C1519/A16463Department of HealthWellcome Trust 102407/Z/13/Z
6 · The paper itself

Abstract

Positron emission tomography (PET) is unique in that it allows quantification of biochemical processes in vivo, but difficulties with preparing suitably labelled radiotracers limit its scientific and diagnostic applications. Aromatic [(18)F]fluorination of drug-like small molecules is particularly challenging as their functional group compositions often impair the labelling efficiency. Herein, we report a new strategy for incorporation of (18)F into highly functionalized aromatic compounds using sulfonium salts as leaving groups. The method is compatible with pharmacologically relevant functional groups, including aliphatic amines and basic heterocycles. Activated substrates react with [(18)F]fluoride at room temperature, and with heating the reaction proceeds in the presence of hydrogen bond donors. Furthermore, the use of electron rich spectator ligands allows efficient and regioselective [(18)F]fluorination of non-activated aromatic moieties. The method provides a broadly applicable route for (18)F labelling of biologically active small molecules, and offers immediate practical benefits for drug discovery and imaging with PET.

Indexed as

Fluorine RadioisotopesIsotope LabelingSaltsSulfonium CompoundsAnimalsMiceModels, AnimalPositron-Emission TomographyRadiopharmaceuticalsTomography, X-Ray ComputedFluorine RadioisotopesRadiopharmaceuticalsSaltsSulfonium Compounds

Identifiers

PMID25898175
PMCPMC4404714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.